Literature DB >> 21885853

MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.

Cristina M Ramirez1, Alberto Dávalos, Leigh Goedeke, Alessandro G Salerno, Nikhil Warrier, Daniel Cirera-Salinas, Yajaira Suárez, Carlos Fernández-Hernando.   

Abstract

OBJECTIVE: The ATP-binding cassette transporter A1 (ABCA1) is a major regulator of macrophage cholesterol efflux and protects cells from excess intracellular cholesterol accumulation; however, the mechanism involved in posttranscriptional regulation of ABCA1 is poorly understood. We previously showed that microRNA-33 (miR-33) is 1 regulator. Here, we investigated the potential contribution of other microRNAs (miRNAs) to posttranscriptional regulation of ABCA1 and macrophage cholesterol efflux. METHODS AND
RESULTS: We performed a bioinformatic analysis for identifying miRNA target prediction sites in ABCA1 gene and an unbiased genome-wide screen to identify miRNAs modulated by cholesterol excess in mouse peritoneal macrophages. Quantitative real-time reverse transcription-polymerase chain reaction confirmed that miR-758 is repressed in cholesterol-loaded macrophages. Under physiological conditions, high dietary fat excess in mice repressed miR-758 both in peritoneal macrophages and, to a lesser extent, in the liver. In mouse and human cells in vitro, miR-758 repressed the expression of ABCA1, and conversely, the inhibition of this miRNA by using anti-miR-758 increased ABCA1 expression. In mouse cells, miR-758 reduced cellular cholesterol efflux to apolipoprotein A1 (apoA1), and anti-miR-758 increased it. miR-758 directly targets the 3'-untranslated region of Abca1 as assessed by 3'-untranslated region luciferase reporter assays. Interestingly, miR-758 is highly expressed in the brain, where it also targets several genes involved in neurological functions, including Slc38a1, Ntm, Epha7, and Mytl1.
CONCLUSION: We identified miR-758 as a novel miRNA that posttranscriptionally controls ABCA1 levels in different cells and regulates macrophage cellular cholesterol efflux to apoA1, opening new avenues to increase apoA1 and raise high-density lipoprotein levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21885853      PMCID: PMC3298756          DOI: 10.1161/ATVBAHA.111.232066

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  37 in total

Review 1.  Tangier disease and ABCA1.

Authors:  J F Oram
Journal:  Biochim Biophys Acta       Date:  2000-12-15

2.  Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transport.

Authors:  Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-01       Impact factor: 8.311

Review 3.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

4.  Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.

Authors:  S Mott; L Yu; M Marcil; B Boucher; C Rondeau; J Genest
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

5.  MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.

Authors:  Takahiro Horie; Koh Ono; Masahito Horiguchi; Hitoo Nishi; Tomoyuki Nakamura; Kazuya Nagao; Minako Kinoshita; Yasuhide Kuwabara; Hiroyuki Marusawa; Yoshitaka Iwanaga; Koji Hasegawa; Masayuki Yokode; Takeshi Kimura; Toru Kita
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

6.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Authors:  S M Clee; J J Kastelein; M van Dam; M Marcil; K Roomp; K Y Zwarts; J A Collins; R Roelants; N Tamasawa; T Stulc; T Suda; R Ceska; B Boucher; C Rondeau; C DeSouich; A Brooks-Wilson; H O Molhuizen; J Frohlich; J Genest; M R Hayden
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 7.  Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal.

Authors:  John M Dietschy; Stephen D Turley
Journal:  J Lipid Res       Date:  2004-08       Impact factor: 5.922

8.  ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

Authors:  Suzanne E Wahrle; Hong Jiang; Maia Parsadanian; Justin Legleiter; Xianlin Han; John D Fryer; Tomasz Kowalewski; David M Holtzman
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.

Authors:  Veronica Hirsch-Reinshagen; Steven Zhou; Braydon L Burgess; Lise Bernier; Sean A McIsaac; Jeniffer Y Chan; Gavin H Tansley; Jeffrey S Cohn; Michael R Hayden; Cheryl L Wellington
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

10.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

Authors:  Nan Wang; Wengen Chen; Patrick Linsel-Nitschke; Laurent O Martinez; Birgit Agerholm-Larsen; David L Silver; Alan R Tall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more
  100 in total

Review 1.  Genetics of cholesterol efflux.

Authors:  Iulia Iatan; Aurélien Palmyre; Sarah Alrasheed; Isabelle Ruel; Jacques Genest
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  MicroRNAs regulating lipid metabolism in atherogenesis.

Authors:  K J Rayner; C Fernandez-Hernando; K J Moore
Journal:  Thromb Haemost       Date:  2012-01-25       Impact factor: 5.249

Review 3.  MicroRNA control of high-density lipoprotein metabolism and function.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

4.  Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein.

Authors:  Kasey C Vickers; Kathryn J Moore
Journal:  Circ Res       Date:  2013-11-08       Impact factor: 17.367

Review 5.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

Review 6.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 7.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

Review 8.  The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

9.  Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site.

Authors:  Kris Richardson; Jennifer A Nettleton; Noemi Rotllan; Toshiko Tanaka; Caren E Smith; Chao-Qiang Lai; Laurence D Parnell; Yu-Chi Lee; Jari Lahti; Rozenn N Lemaitre; Ani Manichaikul; Margaux Keller; Vera Mikkilä; Julius Ngwa; Frank J A van Rooij; Christie M Ballentyne; Ingrid B Borecki; L Adrienne Cupples; Melissa Garcia; Albert Hofman; Luigi Ferrucci; Dariush Mozaffarian; Mia-Maria Perälä; Olli Raitakari; Russell P Tracy; Donna K Arnett; Stefania Bandinelli; Eric Boerwinkle; Johan G Eriksson; Oscar H Franco; Mika Kähönen; Michael Nalls; David S Siscovick; Denise K Houston; Bruce M Psaty; Jorma Viikari; Jacqueline C M Witteman; Mark O Goodarzi; Terho Lehtimäki; Yongmei Liu; M Carola Zillikens; Yii-Der I Chen; André G Uitterlinden; Jerome I Rotter; Carlos Fernandez-Hernando; Jose M Ordovas
Journal:  Am J Hum Genet       Date:  2012-12-13       Impact factor: 11.025

Review 10.  MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Authors:  Neetu Sud; Jennifer Taher; Qiaozhu Su
Journal:  Drug Dev Res       Date:  2015-08-19       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.